Effect and safety of botulinum toxin A injection in external urethral sphincter for male patients with neurogenic detrusor underactivity

Effect and safety of botulinum toxin A injection in external urethral sphincter for patients with neurogenic detrusor underactivity

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021864

Enrollment

Unknown

Registered

2019-03-13

Start date

2019-03-15

Completion date

Unknown

Last updated

2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic Detrusor Underactivity

Interventions

study group:100 U BTX-A injection at the 3-o’clock, 6-o’clock, 9-o’clock,and 12-o’clock positions in approximate equal aliquots in external urethral sphincter

Eligibility

Sex/Gender

Male

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Male patients with neurogenic detrusor underactivity were recruited.

Exclusion criteria

Exclusion criteria: (1) Patients allergic to btx-a; (2) Patients with bladder stone; (3) Patients with BPH; (4) Acute urinary tract infection.

Design outcomes

Primary

Measure	Time frame
PVR;Qmax;det.max;	—

Countries

china

Contacts

Public ContactHui Chen

doc.chenhui@163.com+86 13611413588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026